KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Accured Expenses (2020 - 2026)

Boston Scientific's Change in Accured Expenses history spans 7 years, with the latest figure at -$512.0 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 32.99% to -$512.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $169.0 million, a 45.13% decrease, with the full-year FY2025 number at $296.0 million, up 21.81% from a year prior.
  • Change in Accured Expenses hit -$512.0 million in Q1 2026 for Boston Scientific, down from $285.0 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for BSX hit a ceiling of $385.0 million in Q4 2024 and a floor of -$512.0 million in Q1 2026.
  • Historically, Change in Accured Expenses has averaged -$6.5 million across 5 years, with a median of $23.0 million in 2023.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 5357.14% in 2022 and later surged 1573.91% in 2024.
  • Tracing BSX's Change in Accured Expenses over 5 years: stood at $335.0 million in 2022, then plummeted by 93.13% to $23.0 million in 2023, then surged by 1573.91% to $385.0 million in 2024, then decreased by 25.97% to $285.0 million in 2025, then tumbled by 279.65% to -$512.0 million in 2026.
  • Business Quant data shows Change in Accured Expenses for BSX at -$512.0 million in Q1 2026, $285.0 million in Q4 2025, and $165.0 million in Q3 2025.